目的 系統評價和分析17國國家藥物政策的主要內容，為建立適合我國國情的國家藥物政策提供決策依據。
方法 共檢索13個電子數據庫、WHO、世界銀行和17國藥品管理相關網站，用預先設計的數據提取表收集相關信息，根據設計的理論框架對提取的信息進行分析和描述。
結果 共納入17個國家的182篇文獻，各國藥物政策共同關注的要點是：藥品規制和質量保障、合理用藥、藥品供應、基本藥物遴選、人力資源開發與培訓、傳統醫藥、藥品籌資和可支付能力、藥品研究、藥物政策的監測和評估、技術合作和本國醫藥產業發展。我國在藥物遴選、質量保障、供應、定價及傳統醫藥等方面開展工作，而對藥品研究、政策監測、本國醫藥發展和技術合作方面還有待進一步加強。
結論 建議籌備相關組織機構和規范工作程序，推動國家基本藥物政策相關立法工作，健全基本藥物目錄的遴選機制和配套實施政策，整頓藥品生產流通秩序，建立科學合理的藥品定價機制和基本藥物可及性評估體系，加強藥物政策的監測與評估，適時更新和完善國家藥物政策。
引用本文： 王莉,喻佳潔,周幫旻,李幼平,成嵐,袁強,李玲,陳群飛,高霑,崔曉華. 17國國家藥物政策的系統評價. 中國循證醫學雜志, 2009, 09(7): 715-729. doi: 10.7507/1672-2531.20090127 復制
| 1. | File/qumresearch.pdf, 2008.12. |
| 2. | File/augudddc.pdf, 2008.12. |
| 3. | File/qumchildren.pdf, 2008.12. |
| 4. | File/qumresearch.pdf, 2008.12. |
| 5. | File/nmp2000.pdf, 2008.12. |
| 6. | WHO. How to develop and implement a national drug policy. http://whqlibdoc.who.int/hq/2002/WHO_EDM_TRM_2002.1_chi.pdf.2008.12. |
| 7. | WHO. WHO Medicines Strategy: 2004-2007, Countries at the core. http://www.who.int/medicinedocs/collect/medicinedocs/pdf/s5416e/s5416e.pdf. 2008.12. |
| 8. | 覃正碧, 汪志宏, 程剛. 國家基本藥物制度的現狀及其完善對策探討. 中國藥房, 2008, 19(14): 1041-1044. |
| 9. | Unknown, 2009年全國衛生會議工作召開, 陳竺: 做好六項工作. http://www.gov.cn/gzdt/2009-01/08/content_1199449.htm. 2009.1. |
| 10. | Zweygarth M, Summers RS. A national database for essential drugs in South Africa. Pharm World Sci, 2000, 22(3): 116-117. |
| 11. | Tomson G, Paphassarang C, Jonsson K, et al. Decision-makers and the usefulness of research evidence in policy implementation-A case study from Lao PDR. Soc Sci Med, 2005, 61(6): 1291-1299. |
| 12. | Stenson B, Tomson G, Syhakhang L. Pharmaceutical regulation in context: the case of Lao People’s Democratic Republic. Health Policy Plan, 1997, 12(4): 329-340. |
| 13. | Paphassarang C, Wahlstrom R, Phoummalaysith B, et al. Building the National Drug Policy on evidence: A cross sectional study on assessing implementation in Lao PDR. Southeast Asian Journal of Tropical Medicine & Public Health, 2002, 33(3): 647-653. |
| 14. | Chaulagai CN. Community financing for essential drugs in Nepal. World Health Forum, 1995, 16(1): 92-94. |
| 15. | Scott DL, Alder S, Usui E, et al. Orphan drug programs/policies in Australia, Japan, and Canada. Drug Information Journal, 2001, 35(1): 1-16. |
| 16. | Tett SE. A perspective on Australia’s National Medicines Policy. Can J Clin Pharmacol, 2004, 11(1): 28-38. |
| 17. | Doran E, Alexander Henry D. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia. J Public Health Policy, 2008, 29(1): 106-120. |
| 18. | Hailey D. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. Soc Sci Med, 1997, 45(4): 563-581. |
| 19. | Lofgren H, Boer Rd. Pharmaceuticals in Australia: developments in regulation and governance. Soc Sci Med, 2004, 58(12): 2397-2407. |
| 20. | Morgan S, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia. Health Policy, 2008, 87(2): 133-145. |
| 21. | Louis WJ. Conflict over drug policy in Australia. BMJ, 1989, 298(6672): 472-473. |
| 22. | Henry DA, Hill SR, Harris A. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme. JAMA, 2005, 294(20): 2630-2632. |
| 23. | Duckett SJ. Drug policy down under: Australia’s Pharmaceutical Benefits Scheme. Health Care Finan Rev, 2004, 25(3): 55-67. |
| 24. | Roughead EE, Monteith GR, Harvey KJ, et al. Evaluating Australia’s National Medicines Policy using geographical mapping. Intern Med J, 2002, 32(3): 66-71. |
| 25. | Weerasuriya K. Essential drugs and registration of pharmaceuticals: the Sri Lankan experience. Bull World Health Organ, 1993, 71(2): 229-35. |
| 26. | Bossert TJ, Bowser DM, Amenyah JK. Is decentralization good for logistics systems? Evidence on essential medicine logistics in Ghana and Guatemala. Health Policy Plan, 2007, 22(2): 73-82. |
| 27. | Khan I. What action for rational drug use? World Health Forum, 1997, 18(1): 83-86. |
| 28. | Anokbonggo WW, Ogwal-Okeng JW, Obua C, et al. Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs. East Afr Med J, 2004, Suppl: S2-7. |
| 29. | Chetley A. Bangladesh: Changes to drug policy. Lancet, 1992, 340(8830): 1280-1281. |
| 30. | Chetley A. Bangladesh: Delays for revised drug policy. Lancet, 1993, 341: 622-845. |
| 31. | Islam MS. Therapeutic drug use in Bangladesh: policy versus practice. Indian J Med Ethics, 2008, 5(1): 24-25. |
| 32. | Mirza Z. Islamabad - Non-emergence of Pakistan’s national drug policy. Lancet, 1996, 348(9020): 119. |
| 33. | Anis AH. Pharmaceutical policies in Canada: another example of federal-provincial discord. Canadian Medical Association Journal, 2000, 162(4): 523-526. |
| 34. | Angus DE, Karpetz HM. Pharmaceutical policies in Canada - Issues and challenges. Pharmacoeconomics, 1998, 14: 81-96. |
| 35. | Hollis A, Ibbott P. How parallel trade affects drug policies and prices in Canada and the United States. Am J Law Med, 2006, 32(2-3): 193-217. |
| 36. | Al-Sukhni M, Ballantyne P. Pharmaceutical-related strategies for health care reform in Canada: Federal party principles, priorities, and actions 2004-2006. Canadian Pharmacists Journal, 2007, 140(1): 38-45. |
| 37. | Lexchin J. After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics. Health Policy, 1997, 40(1): 69-80. |
| 38. | Farrell J, Ries NM, Boon H. Pharmacists and natural health products: A systematic analysis of professional responsibilities in Canada. Pharmacy Practice, 2008, 6(1): 33-42. |
| 39. | Lexchin J. A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences. Health Policy, 2006, 79(2-3): 214-220. |
| 40. | Anis AH, Wen Q. Price regulation of pharmaceuticals in Canada. J Health Econ, 1998, 17(1): 21-38. |
| 41. | LeLorier J, Rawson NSB. Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand. Canadian Journal of Cardiology, 2007, 23(9): 711-718. |
| 42. | Cheung RY, Cohen JC, Illingworth P. Orphan drug policies: implications for the United States, Canada, and developing countries. Health Law J, 2004, 12: 183-200. |
| 43. | Saleh K, Ibrahim MIM. Are essential medicines in Malaysia accessible, affordable and available? Pharm World Sc, 2005, 27(6): 442-446. |
| 44. | Kotwani A, Ewen M, Dey D, et al. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res, 2007, 125(5): 645-654. |
| 45. | Shah MB, Patel AS. Drug price control in India - An overview. Journal of Pharmaceutical Finance, Economics and Policy, 2003, 12(2): 123-131. |
| 46. | Yang J. Essential drugs in China. World Health Forum, 1986, 7(1): 82-83. |
| 47. | Sun Q, Santoro MA, Meng QY, et al. Pharmaceutical policy in China. Health Affairs, 2008, 27(4): 1042-1050. |
| 48. | Yin H. Regulations and procedures for new drug evaluation and approval in China. Human Gene Therapy, 2006, 17(10): 970-974. |
| 49. | 楊軍華, 張新平. 促進合理用藥的國際經驗與啟示. 中國衛生經濟, 2005, 24(6): 53-57. |
| 50. | 符策慧. 國家推行基本藥物制度. 中國醫療前沿, 2007, (7): 18. |
| 51. | 江濱, 鄢尤奇, 史錄文. 近年來我國藥品監管政策分析. 中國藥事, 2005, 19(3): 148-150. |
| 52. | 車明鳳, 韓白石. 我國頒布實施《國家基本藥物目錄》的概況. 中國藥事, 2000, 14(1): 19-21. |
| 53. | 許鳳奎. 我國基本藥物遴選工作概況. 中國醫院管理, 1997, 17(4): 23-24. |
| 54. | 張震巍, 陳飛虎. 我國制訂與實施《國家基本藥物目錄》的進展. 西部藥學, 2004, 1(1): 12-16. |
| 55. | 陳卓蕾, 陳文, 蔣虹麗, 等. 醫藥費用控制相關政策分析(三)——藥品費用控制政策. 中國衛生資源. 2007, (04): 76-79. |
| 56. | 錢麗萍, 劉佳, 張新平. 中印基本藥物和合理用藥政策比較. 中國衛生事業管理, 2003, 19(6): 381-383. |
| 57. | An Act Regulating the Practice of Pharmacy. Senate and House of Representative of the Philippines. http://www.doh.gov.ph/ra/ra5921, 2008.12. |
| 58. | Food, Drug, and Cosmetic Act, Senate and House of Representative of the Philippines. http://www.bfad.gov.ph/, 2008. |
| 59. | National Health Insurance Act of 1995, government of Philippines. http://www.doh.gov.ph/node/154/pdf, 2008.12. |
| 60. | Price Act, Congress Of Philipplines., http://www.bfad.gov.ph/, 2008.12. |
| 61. | Badoy TJ, Implementing the Essential Drugs List the Philippine Experience. http://www.doh.gov.ph/files/ao2006-0018.pdf.2008.12. |
| 62. | The Generics Act of 1988, Congress Of Philipplines. http://www.bfad.gov.ph/, 2008.12. |
| 63. | Special Law on Counterfeit Drugs, Congress Of Philipplines. http://www.bfad.gov.ph/, 2008.12. |
| 64. | Traditional & Alternative Medicine Act of 1997, Congress Of Philipplines. http://www.doh.gov.ph/node/143/pdf, 2008.12. |
| 65. | Universally Accessible Cheaper and Quality Medicines Act of 2008, Congress Of Philipplines. http://www.doh.gov.ph/ra/cheaper_drugs, 2008.12. |
| 66. | General Regulations for the Enforcement of the Food, Drug & Cosmetic, Department Of Health Office Of The Secretary. http://www.bfad.gov.ph/AO/ao%2061%20s%201968.pdf, 2008.12. |
| 67. | Guidelines on the Pilot Implementation of the Electronic Essential Drug Price Monitoring(e-EDPMS), Office Of The Senate, http://www.doh.gov.ph/files/ao2008-0014_0.pdf, 2008.12. |
| 68. | Guidelines Institutionalizing and Strengthening the Essential Drug Price Monitoring System(EDPMS), Office Of The Senate. http://www.bfad.gov.ph/AO/ao2006-0009_doh.pdf, 2006. |
| 69. | Reporting Adverse Drug Reactions In South Africa, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=17&Desc=Guidelines%20-%20Human%20Medicines, 2008.12. |
| 70. | Draft Policy on African Traditional Medicine for South Africa, National Ethics Committee for African Traditional Medicine. Medicines Control Council. http://www.doh.gov.za/, 2008.12. |
| 71. | General Regulations Made In Terms Of The Medicines And Related Substances Act, 1965 (Act No. 101 Of 1965), As Amended, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=27&Desc=Acts%20and%20Regulations, 2008.12. |
| 72. | Medicines and Related Substances Act, 1965, Government Gazette, http://www.mccza.com/showdocument.asp?Cat=27&Desc=Acts%20and%20Regulations, 2008. |
| 73. | Medicines and Related Substances Control Amendment Bill, 1997. http://www.hst.org.za/pphc/Phila/medbill.htm, 2008.12. |
| 74. | Pharmacy Amendment Act, No.6 of 1995. Office Of The President, http://www.doh.gov.za/docs/pharmis-f.html, 2008.12. |
| 75. | Pharmacy Amendment Act, No.88 of 1997. Office Of The President, http://www.doh.gov.za/docs/pharmis-f.html, 2008.12. |
| 76. | Pharmacy Amendment Act, No. 1 of 2000, Office Of The President, http://www.doh.gov.za/docs/pharmis-f.html, 2008.12. |
| 77. | Fees Payable To The Registrar, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=2, 2008.12. |
| 78. | Andy Gray. Drug Pricing, http://www.hst.org.za/uploads/files/drugs.p, 2008.12. |
| 79. | Guide To Good Manufacturing Practice For Medicines In South Africa, Medicines Control Council, http://www.mccza.com/showdocument.asp?Cat=1, 2008.12. |
| 80. | Guideline For The Direct Transmission Of Fees Payable To The Registrar Of Medicines, Medicines Control Council, http://www.mccza.com/showdocument.asp?Cat=2, 2008.12. |
| 81. | Guidelines On Inspections Involving The GMP Inspectors, Medicines Control Council, http://www.mccza.com/showdocument.asp?Cat=1, 2008.12. |
| 82. | The impact of rationalised pharmaceutical procurement and distribution and of the essential drugs programme implementation, MEDUNSA School of Pharmacy. http://www.hst.org.za/uploads/files/drgmx_n. 2008.12. |
| 83. | Implementation Of The Post-Registration Amendments Guideline, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=17&Desc=Guidelines%20-%20Human%20Medicines, 2008.12. |
| 84. | Package Inserts For Human Medicines, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=17&Desc=Guidelines%20-%20Human%20Medicines, 2008. |
| 85. | 南非藥品信息體系, http://www.doh.gov.za/department/clus_pharma.html, 2008.12. |
| 86. | Bhutan Medicines Rules & Regulations 2005. Kingdom of Bhutan. http://www.health.gov.bt/downloads/EnglishRegulations.pdf. 2005. |
| 87. | Guidelines for application for Registration of Medicinal Products 2006(DRA). Drug regulatory authority, http://www.health.gov.bt/downloads/draRegisGuidenew.pdf, 2008.12. |
| 88. | The Medicines Act Of The Kingdom Of Bhutan 2003. http://www.health.gov.bt/downloads/EnglishMedicinesAct.pdf, 2008.12. |
| 89. | Procurement Manual rules and procedures 2007 . Royal Government of Bhutan Ministry of Finance, http://www.health.gov.bt/downloads/procurementmanual.pdf, 2008.12. |
| 90. | Bell JF. Guideline On Continuing Medical Education, ministry of health http://www.health.gov.bt/downloads/CMEguideline07.pdf. |
| 91. | Drugs, vaccines and equipment division, procurement procedures. ministry of health, http://www.health.gov.bt/dms/dved/procurementProc.pdf, 2008.12. |
| 92. | Drug Act. 2035 (1978). http://www.dda.gov.np/drugact.php, 2008.12. |
| 93. | Guidelines on Ethical Promotion of Medicine, 2007. http://www.dda.gov.np/guidance.php, 2008.12. |
| 94. | Guidelines on Labelling. Department of Drug Administration. http://www.dda.gov.np/guidance.php, 2008.12. |
| 95. | National Good Pharmacy Practice Guidelines. Nepal Pharmacy Council. http://www.dda.gov.np/guidlines/national_gp, 2008.12. |
| 96. | Bijulibazar, Kathmandu. Report On Consumption And Quantification Of Modern Drugs For Human Use In Nepal. Department of Drug Administration. http://www.dda.gov.np/quantification/quanti_2001.pdf, 2008.12. |
| 97. | Bijulibazar, Kathmandu. Report On Quantification Of Drug Consumption In Nepal. Department of Drug Administration. http://www.dda.gov.np/quantification/quanti_2006.pdf, 2008.12. |
| 98. | Guidelines for Drug Donations. Government of Nepal. http://www.dda.gov.np/guidlines/other_guidence.pdf, 2008.12. |
| 99. | Rational Drug Use. The Directorate General Of Pharmaceutical Affairs And Drug Control. http://www.moh.gov.om/pharma/rdupeng.pdf, 2008.12. |
| 100. | Quality Use Of Medicines-– A Decade Of Research,Development And Service Activity. Pharmaceutical Health and Rational use of Medicines Committee. http://www.health.gov.au/internet/main/publishing.nsf/Content/AEC9F819EA0345F7CA256F1800468F04/. |
| 101. | Australian guidelines for drug donations to developing countries. Australian Pharmaceutical Advisory Council. http://www.health.gov.au/internet/main/publishing.nsf/Content/035470C60EE4E52FCA256F1800468850/. |
| 102. | The Quality Use of Medicines and Children. Pharmaceutical Health And Rational use of Medicines (PHARM) Committee. http://www.health.gov.au/internet/main/publishing.nsf/Content/55E55D36126F25F7CA2573FC00062A82/. |
| 103. | The Therapeutic Goods Administration’s risk management approach to the regulation of therapeutic goods. Department Of Health And Ageing Therapeutic Goods Administration. http://www.tga.gov.au/about/tgariskmnt.pdf, 2008.12. |
| 104. | Policies, Procedures And Methods Used In The Pricing Of Pharmaceutical Products. Pharmaceutical Benefits Pricing Authority. Http://Www.Health.Gov.Au/, 2008.12. |
| 105. | The National Strategy for Quality Use of Medicines. Pharmaceutical Health And Rational use of Medicines (PHARM) Committee. http://www.health.gov.au/internet/main/publishing.nsf/Content/AEC9F819EA0345F7CA256F1800468F04/. |
| 106. | The Expectations, the Reality And The Burden Of Drug Donations. Ministy of Healthcare & Nutrition. http://www.health.gov.lk/msd/Page1-9MSD.pdf, 2008.12. |
| 107. | Dr Nihal Jayathilaka. Improving access to affordable essential drugs. Ministry of health.http://www.wpro.who.int/NR/rdonlyres/1A29C051-DE36-4521-AB7B-812E8274456D/0/03SriLanka2A1.pdf. 2008.12. |
| 108. | Sri Lanka National Health System Profile. http://www.health.gov.lk/, 2008.12. |
| 109. | F. K. HLORTSI-AKAKPO, Traditional Medicine. Traditional Medicine Practice Council, http://www.moh-ghana.org/moh/aboutus/policies.asp, 2008. |
| 110. | Drugs (Licensing, Registering And Advertising) Rules, 1976. the Federal Government, http://www.dcomoh.gov.pk/regulations/drugrules5.php, 2008.12. |
| 111. | The Drugs Act. http://www.dcomoh.gov.pk/regulations/pharmacyact1967.php, 2008.12. |
| 112. | Guidelines For cGMP Inspection of Biological Drugs. Ministry of Health. http://www.dcomoh.gov.pk/, 2008.12. |
| 113. | Guildline For Registration of Biological Drugs. Ministry of Health. http://www.dcomoh.gov.pk/, 2008.12. |
| 114. | Pakistan- An Introduction. http://www.dcomoh.gov.pk/, 2008.12. |
| 115. | The Drugs (Labelling and Packing) Rules, http://www.dcomoh.gov.pk/, 2008.12. |
| 116. | Problem of Irrational Drug Use. Pakistan drug update. http://www.dcomoh.gov.pk/, 2008.12. |
| 117. | Mohammad Saidul Islam. How Complementary and Alternative Medicine (CAM) is promoted in Bangladesh. The Internet Journal of Alternative Medicine, 2008, 5(2): 1450-1458. |
| 118. | The Drugs (Control) Ordinance, http://www.mohfw.gov.bd/, 1982. |
| 119. | Drug Registration Procedure And Requirements In Bangladesh. http://www.mohfw.gov.bd/drug%20registration.htm, 2008.12. |
| 120. | Drug Act, Government of Bangladesh. 2008.12. |
| 121. | Code Of Pharmaceutical Marketing Practices. Drugs Administration Ministry of Health And Family Welfare, http://www.mohfw.gov.bd/, 2008.12. |
| 122. | Regulations, Policies and Standards in Pharmaceutical Industry. Directorate of Drugs Administration, http://www.mohfw.gov.bd/, 2008.12. |
| 123. | The Bengal Drugs Rules, Government of East Bengal Health and LocalSelf-GovernmentDepartment. 2008.12. |
| 124. | Bruce Carleton. Post-Marketing Pharmacosurveillance In Canada. http://www.hc-sc.gc.ca/dhp-mps/index-eng.php, 2008.12. |
| 125. | Wendy Kennedy. The Health Transition Fund (Pharmaceutical Issues). http://www.hc-sc.gc.ca, 2008.12. |
| 126. | A Comparison of Pharmaceutical Reaseach and Development Spending. Patented Medicine Prices Review Board, http://www.mohfw.gov.bd/, 2008.12. |
| 127. | Access to Therapeutic Products in Canada, ministry of health. http://www.mohfw.gov.bd/, 2008.12. |
| 128. | National Pharmaceuticals Strategy (NPS). ministry of health. http://www.mohfw.gov.bd/, 2008.12. |
| 129. | Gary Fox, Medicines that Work for Canadians (Business Plan for a Drug Effectiveness and Safety Network). http://www.mohfw.gov.bd/, 2008.12. |
| 130. | Traditional and Complementary Medicine. http://www.myhealth.gov.my/myhealth/eng/ubat_anda_content.jsp?lang=ubat&storymaster=1225785083091&storyid=1225785618675&sub, 2008.12. |
| 131. | Medicines (Advertisement And Sale)Act, http://www.pharmacy.gov.my/, 2008.12. |
| 132. | Registration of Pharmacists Act, http://www.pharmacy.gov.my, 2008. |
| 133. | 馬來西亞藥品管理體系, http://www.pharmacy.gov.my. 2008.12. |
| 134. | Drug Registration Guidance Document, National Pharmaceutical Control Bureau, http://www.pharmacy.gov.my, 2008. |
| 135. | drug policy, http://www.nppaindia.nic.in/drug_pol86/txt1.html, 2008. |
| 136. | Drugs(Prices Control) Order. Ministry of Chemicals and Fertilizers. http://www.nppaindia.nic.in/drug_price95/txt1.html, 2008.12. |
| 137. | Modifications in Drug Policy. http://www.nppaindianic.in/drug_pol86/modif86/mod1.html, 2008.12. |
| 138. | Pharmaceutical Policy-2002. Prime Minister’s Advisory Council. http://www.nppaindia.nic.in/may-2002/policy-02.html, 2008.12. |
| 139. | Dte.GHS, Central Drugs Standard Control Organization-Laws Pertaining To Manufacture And Sale Of Drugs In India, Ministry of Health and Family Welfare. http://www.cdsco.nic.in/html/law.htm. |
| 140. | The Drugs And Cosmetics Act And Rules. Ministry of Health And Family Welfare. http://www.cdsco.nic.in/html/Copy%20of%201.%20D&CAct121.pdf, 2008.12. |
| 141. | Price Control Order (DPCO), National Pharmaceutical Pricing Authority . http://www.pharmaceutical-drug-manufacturers.com/pharmaceutical-policies/drugs-price-control-order.html, 2008.12. |
| 142. | Procedure for Price Fixation. National Pharmaceutical Pricing Authority, http://www.nppaindia.nic.in/may-2002/procedure-bd.html, 1 2008.12. |
| 143. | Procedure for Pricing of Formulations. National Pharmaceutical Pricing Authority. http://www.nppaindia.nic.in/may2002/procedure-form.html, 2008.12. |
| 144. | Central Drugs Standard Control Organization-Drugs Control Administration. Drugs Control Administration. http://www.cdsco.nic.in/html/Drugs_ContAd.html, 2008.12. |
| 145. | 中華人民共和國藥品管理法, 國家食品藥品監督管理局. http://www.sda.gov.cn/WS01/CL0064/23396.html, 2008.12. |
| 146. | 中華人民共和國藥品管理法實施條例, 國家食品藥品監督管理局. http://www.sda.gov.cn/WS01/CL0062/23395.html, 2008.12. |
| 147. | WHO. Essential medicines: access, quality and rational use – highlights of 2000, www.who.int/mip2001/files/2158/MIP01_APR_HTP2.en.pdf, 2008.12. |
| 148. | WHO. The WHO Essential Medicines List (EML): 30th anniversary. www.who.int/entity/medicines/events/fs/en/, 2008.12. |
| 149. | WHO. Comparative analysis of national drug policies. www.wpro.who.int/NR/rdonlyres/F1EFC301-FD5E-4BEE-9FD7-656965FD882B/0/EDMnewsletterECACPWHOyear2.pdf, 2008.12. |
| 150. | WHO Regional Office of the Western Pacific. Drug Price Control Bills in the Philippines/ Ethical Practices in Medicines Regulation and Procurement. Essential drug & medicine policy, 2008.12. |
| 151. | WHO. The Role of Education in the Rational Use of Medicines. www.wpro.who.int/NR/rdonlyres/8B64881B-DE1A-4A31-B670-B87265FBBB7F/0/EDMP_Dec04.pdf, 2008.12. |
| 152. | WHO. Malaysia formulates national medicines policy. Essential drug & medicine policy, 2002, 1(1):537-542. |
| 153. | WHO. Strengthening ADR Monitoring in the Philippines. Essential drug & medicine policy, 2003, 2(1): 765-769. |
| 154. | WHO. Computerized Drug Registration- The Lao People’s Democratic Republic/ Monitoring and Assessing the Pharmaceutical Situation in Malaysia. Essential drug & medicine policy, 2002, 1(2): 253-258. |
| 155. | WHO. Assessment of the Distribution Practices of Medicines in thePhilippines. Essential drug & medicine policy, 2004, 3(2): 753-760. |
| 156. | WHO. Philippines Chosen as a MeTA Pilot Country/ Cheaper Medicines Bill in the Philippines/ Philippines Develops Quality Seal System for Pharmaceuticals. Essential drug & medicine policy, 2007, 7(3): 341-346. |
| 157. | WHO. Medicines Price Monitoring in Malaysia. Essential drug & medicine policy, 2006, 5(1): 445-448. |
| 158. | WHO. Annual Report 2001:Essential Drugs and Medicines Policy: Extending the Evidence Base. www.who.int/mip2002/index.pl%3Fid=2304&isa=Item&field_name=item_attachment_file&op=download_file, 2008.12. |
| 159. | WHO. How to develop a national formulary based on the WHO model formulary. www.who.int/emlib/docs/National_MF_Manual2004-8.pdf, 2008.12. |
| 160. | WHO. Medicine Prices in Ghana: A comparative study of Public, Private and Mission sector medicine prices. www.afro.who.int/dsd/survey_reports/ghana.pdf, 2008.12. |
| 161. | WHO. Biregional Workshop On Promoting Ethical Practices In Medicines Registration And Procurement., whqlibdoc.who.int/wpro/2006/RS_2005_GE_12_MAA.pdf, 2008.12. |
| 162. | WHO. Essential drugs and other supplies. http://www.searo.who.int/EN/Section313/Section1515_6124.htm, 2008.12. |
| 163. | WHO. rational use of medicines in the lao people’s democratic republic strategy/ combating counterfeit drugs in the lao people’s democratic republic. Essential drug & medicine policy, 2003, 2(2): 752-756. |
| 164. | WHO. Drug Supply Management in the Context of IMCI（Drug Supply and Management Training in South Africa. whqlibdoc. who.int/searo/2001/SEA_Drugs_152.pdf, 2008.12. |
| 165. | WHO. Rational Drug Use (RDU). www.emro.who.int/Publications/EMHJ/1305/article25.htm, 2008.12. |
| 166. | WHO. Use of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce. whqlibdoc.who.int/hq/1994/WHO_DAP_94.21.pdf, 2008.12. |
| 167. | WHO. Uganda pharmaceutical sector baseline survey. whqlibdoc.who.int/hq/2002/a87427_eng.pdf, 2008.12. |
| 168. | WHO. An assessment of the pharmaceutical sector. whqlibdoc.who.int/hq/2002/a87429_eng.pdf, 2008.12. |
| 169. | WHO. Effective drug regulation. www.who.int/entity/medicines/areas/rational_use/startingstrengdrugbulletin.pdf, 2008.12. |
| 170. | WHO. Reports World Medicines Situation. whqlibdoc.who.int/hq/1994/WHO_DAP_94.21.pdf, 2008.12. |
| 171. | WHO. Essential Medicines List. whqlibdoc.who.int/hq/2006/WHO_PSM_PAR_2006.5_eng.pdf, 2008.12. |
| 172. | WHO. Successful partnership in Pakistan for rational use and management of medicines. Essential Drugs in Brief, 2003, 3(9). |
| 173. | WHO. Access to affordable essential medicines. www.who.int/entity/medicines/mdg/MDG08ChapterEMedsEn.pdf, 2008.12. |
| 174. | WHO. Regional Strategy For Improving Access To Essential Medicines In The Western Pacific Region, 2004-2009, 2008.12. |
| 175. | Implementing Guidelines For The Philippines NDP System. Ministry of health. http://www.doh.gov.ph/ndp_issuances, 2008.12. |
| 176. | Lao national drug policy programme. Department for democracy and social development.http://www.globala.sida.se/sida/jsp/sida.jsp?d=118&a=2218&language=en_US, 2008.12. |
| 177. | Oman National Drug Policy. The Directorate General Of Pharmaceutical Affairs And Drug Control. http://www.moh.gov.om/pharma/ndpeng.pdf, 2008.12. |
| 178. | National medicine policy ( Australia ). Department of health and aging. http://www.health.gov.au/internet/main/publishing.nsf/Content/0241A32640D477CACA256F18004685E4/. |
| 179. | National drug policy (Bhutan). Department of Medical Services Ministry of Health Royal Government of Bhutan. http://www.health.gov.bt/downloads/drugPolicy.pdf, 2008.12. |
| 180. | National Drug Policy for South Africa. Minister of Health. http://www.doh.gov.za/docs/policy/drugsjan1996.pdf, 2008.12. |
| 181. | National Drug Policy (Nepal). Commitment of Government Of Nepal. http://www.google.cn/search?hl=zh-CN&newwindow=1&q=National+Drug+Policy+nepal&btnG= Google+%E6%90%9C%E7%B4%A2&meta= &aq=f&oq=, 2008.12. |
| 182. | National Medicinal Drug Policy For SriLanka, http://www.who.int/medicines/areas/policy/NMDP_SriLanka.pdf, 2008.12. |
| 183. | National drug policy (Pakistan). Ministry of health. http://www.dcomoh.gov.pk/publications/ndp.php, 2008.12. |
| 184. | National drug policy (Uganda). The National Drug Authority, http://www.nda.or.ug/index.php, 2008.12. |
| 185. | National Medicine Policy (Afghanistan). Ministry of Health. http://ispb.univ-lyon1.fr/Lyon%20Kaboul/politique_de_sante_en_afghanistan/rapports/Politique%20du%20m%E9dicament.pdf, 2008.12. |
| 186. | National Pharmaceuticals Strategy ( Canada ). Health Canada, http://www.hc-sc.gc.ca/hcs-sss/alt_formats/hpb-dgps/pdf/pubs/2006-nps-snpp/2006-nps-snpp-eng.pdf, 2008.12. |
| 187. | Ghana National Drug Policy. Ministry of Health (GNDP) Ghana, http://www.who.int/countries/gha/publications/Ghana_National_DrugPolicy_2nd_Edition.pdf, 2008.12. |
| 188. | National medicines policy of Malaysia. Ministry of health Malaysia. http://www.pharmacy.gov.my/, 2008.12. |
| 189. | National drug policy (Bangladesh) . Ministry Of Health And Family Welfare . http://www.ailonline.net/skf_new/images/files/. |
| 190. | National_Drug_Policy_May_05.pdf, 2008.12. |
| 191. | 張新平,李少麗. 藥物政策學. 北京: 科學出版社, 2003. |
- 1. File/qumresearch.pdf, 2008.12.
- 2. File/augudddc.pdf, 2008.12.
- 3. File/qumchildren.pdf, 2008.12.
- 4. File/qumresearch.pdf, 2008.12.
- 5. File/nmp2000.pdf, 2008.12.
- 6. WHO. How to develop and implement a national drug policy. http://whqlibdoc.who.int/hq/2002/WHO_EDM_TRM_2002.1_chi.pdf.2008.12.
- 7. WHO. WHO Medicines Strategy: 2004-2007, Countries at the core. http://www.who.int/medicinedocs/collect/medicinedocs/pdf/s5416e/s5416e.pdf. 2008.12.
- 8. 覃正碧, 汪志宏, 程剛. 國家基本藥物制度的現狀及其完善對策探討. 中國藥房, 2008, 19(14): 1041-1044.
- 9. Unknown, 2009年全國衛生會議工作召開, 陳竺: 做好六項工作. http://www.gov.cn/gzdt/2009-01/08/content_1199449.htm. 2009.1.
- 10. Zweygarth M, Summers RS. A national database for essential drugs in South Africa. Pharm World Sci, 2000, 22(3): 116-117.
- 11. Tomson G, Paphassarang C, Jonsson K, et al. Decision-makers and the usefulness of research evidence in policy implementation-A case study from Lao PDR. Soc Sci Med, 2005, 61(6): 1291-1299.
- 12. Stenson B, Tomson G, Syhakhang L. Pharmaceutical regulation in context: the case of Lao People’s Democratic Republic. Health Policy Plan, 1997, 12(4): 329-340.
- 13. Paphassarang C, Wahlstrom R, Phoummalaysith B, et al. Building the National Drug Policy on evidence: A cross sectional study on assessing implementation in Lao PDR. Southeast Asian Journal of Tropical Medicine & Public Health, 2002, 33(3): 647-653.
- 14. Chaulagai CN. Community financing for essential drugs in Nepal. World Health Forum, 1995, 16(1): 92-94.
- 15. Scott DL, Alder S, Usui E, et al. Orphan drug programs/policies in Australia, Japan, and Canada. Drug Information Journal, 2001, 35(1): 1-16.
- 16. Tett SE. A perspective on Australia’s National Medicines Policy. Can J Clin Pharmacol, 2004, 11(1): 28-38.
- 17. Doran E, Alexander Henry D. Australian pharmaceutical policy: price control, equity, and drug innovation in Australia. J Public Health Policy, 2008, 29(1): 106-120.
- 18. Hailey D. Australian economic evaluation and government decisions on pharmaceuticals, compared to assessment of other health technologies. Soc Sci Med, 1997, 45(4): 563-581.
- 19. Lofgren H, Boer Rd. Pharmaceuticals in Australia: developments in regulation and governance. Soc Sci Med, 2004, 58(12): 2397-2407.
- 20. Morgan S, McMahon M, Greyson D. Balancing health and industrial policy objectives in the pharmaceutical sector: Lessons from Australia. Health Policy, 2008, 87(2): 133-145.
- 21. Louis WJ. Conflict over drug policy in Australia. BMJ, 1989, 298(6672): 472-473.
- 22. Henry DA, Hill SR, Harris A. Drug prices and value for money: the Australian Pharmaceutical Benefits Scheme. JAMA, 2005, 294(20): 2630-2632.
- 23. Duckett SJ. Drug policy down under: Australia’s Pharmaceutical Benefits Scheme. Health Care Finan Rev, 2004, 25(3): 55-67.
- 24. Roughead EE, Monteith GR, Harvey KJ, et al. Evaluating Australia’s National Medicines Policy using geographical mapping. Intern Med J, 2002, 32(3): 66-71.
- 25. Weerasuriya K. Essential drugs and registration of pharmaceuticals: the Sri Lankan experience. Bull World Health Organ, 1993, 71(2): 229-35.
- 26. Bossert TJ, Bowser DM, Amenyah JK. Is decentralization good for logistics systems? Evidence on essential medicine logistics in Ghana and Guatemala. Health Policy Plan, 2007, 22(2): 73-82.
- 27. Khan I. What action for rational drug use? World Health Forum, 1997, 18(1): 83-86.
- 28. Anokbonggo WW, Ogwal-Okeng JW, Obua C, et al. Impact of decentralization on health services in Uganda: a look at facility utilization, prescribing and availability of essential drugs. East Afr Med J, 2004, Suppl: S2-7.
- 29. Chetley A. Bangladesh: Changes to drug policy. Lancet, 1992, 340(8830): 1280-1281.
- 30. Chetley A. Bangladesh: Delays for revised drug policy. Lancet, 1993, 341: 622-845.
- 31. Islam MS. Therapeutic drug use in Bangladesh: policy versus practice. Indian J Med Ethics, 2008, 5(1): 24-25.
- 32. Mirza Z. Islamabad - Non-emergence of Pakistan’s national drug policy. Lancet, 1996, 348(9020): 119.
- 33. Anis AH. Pharmaceutical policies in Canada: another example of federal-provincial discord. Canadian Medical Association Journal, 2000, 162(4): 523-526.
- 34. Angus DE, Karpetz HM. Pharmaceutical policies in Canada - Issues and challenges. Pharmacoeconomics, 1998, 14: 81-96.
- 35. Hollis A, Ibbott P. How parallel trade affects drug policies and prices in Canada and the United States. Am J Law Med, 2006, 32(2-3): 193-217.
- 36. Al-Sukhni M, Ballantyne P. Pharmaceutical-related strategies for health care reform in Canada: Federal party principles, priorities, and actions 2004-2006. Canadian Pharmacists Journal, 2007, 140(1): 38-45.
- 37. Lexchin J. After compulsory licensing: coming issues in Canadian pharmaceutical policy and politics. Health Policy, 1997, 40(1): 69-80.
- 38. Farrell J, Ries NM, Boon H. Pharmacists and natural health products: A systematic analysis of professional responsibilities in Canada. Pharmacy Practice, 2008, 6(1): 33-42.
- 39. Lexchin J. A comparison of new drug availability in Canada and the United States and potential therapeutic implications of differences. Health Policy, 2006, 79(2-3): 214-220.
- 40. Anis AH, Wen Q. Price regulation of pharmaceuticals in Canada. J Health Econ, 1998, 17(1): 21-38.
- 41. LeLorier J, Rawson NSB. Lessons for a national pharmaceuticals strategy in Canada from Australia and New Zealand. Canadian Journal of Cardiology, 2007, 23(9): 711-718.
- 42. Cheung RY, Cohen JC, Illingworth P. Orphan drug policies: implications for the United States, Canada, and developing countries. Health Law J, 2004, 12: 183-200.
- 43. Saleh K, Ibrahim MIM. Are essential medicines in Malaysia accessible, affordable and available? Pharm World Sc, 2005, 27(6): 442-446.
- 44. Kotwani A, Ewen M, Dey D, et al. Prices & availability of common medicines at six sites in India using a standard methodology. Indian J Med Res, 2007, 125(5): 645-654.
- 45. Shah MB, Patel AS. Drug price control in India - An overview. Journal of Pharmaceutical Finance, Economics and Policy, 2003, 12(2): 123-131.
- 46. Yang J. Essential drugs in China. World Health Forum, 1986, 7(1): 82-83.
- 47. Sun Q, Santoro MA, Meng QY, et al. Pharmaceutical policy in China. Health Affairs, 2008, 27(4): 1042-1050.
- 48. Yin H. Regulations and procedures for new drug evaluation and approval in China. Human Gene Therapy, 2006, 17(10): 970-974.
- 49. 楊軍華, 張新平. 促進合理用藥的國際經驗與啟示. 中國衛生經濟, 2005, 24(6): 53-57.
- 50. 符策慧. 國家推行基本藥物制度. 中國醫療前沿, 2007, (7): 18.
- 51. 江濱, 鄢尤奇, 史錄文. 近年來我國藥品監管政策分析. 中國藥事, 2005, 19(3): 148-150.
- 52. 車明鳳, 韓白石. 我國頒布實施《國家基本藥物目錄》的概況. 中國藥事, 2000, 14(1): 19-21.
- 53. 許鳳奎. 我國基本藥物遴選工作概況. 中國醫院管理, 1997, 17(4): 23-24.
- 54. 張震巍, 陳飛虎. 我國制訂與實施《國家基本藥物目錄》的進展. 西部藥學, 2004, 1(1): 12-16.
- 55. 陳卓蕾, 陳文, 蔣虹麗, 等. 醫藥費用控制相關政策分析(三)——藥品費用控制政策. 中國衛生資源. 2007, (04): 76-79.
- 56. 錢麗萍, 劉佳, 張新平. 中印基本藥物和合理用藥政策比較. 中國衛生事業管理, 2003, 19(6): 381-383.
- 57. An Act Regulating the Practice of Pharmacy. Senate and House of Representative of the Philippines. http://www.doh.gov.ph/ra/ra5921, 2008.12.
- 58. Food, Drug, and Cosmetic Act, Senate and House of Representative of the Philippines. http://www.bfad.gov.ph/, 2008.
- 59. National Health Insurance Act of 1995, government of Philippines. http://www.doh.gov.ph/node/154/pdf, 2008.12.
- 60. Price Act, Congress Of Philipplines., http://www.bfad.gov.ph/, 2008.12.
- 61. Badoy TJ, Implementing the Essential Drugs List the Philippine Experience. http://www.doh.gov.ph/files/ao2006-0018.pdf.2008.12.
- 62. The Generics Act of 1988, Congress Of Philipplines. http://www.bfad.gov.ph/, 2008.12.
- 63. Special Law on Counterfeit Drugs, Congress Of Philipplines. http://www.bfad.gov.ph/, 2008.12.
- 64. Traditional & Alternative Medicine Act of 1997, Congress Of Philipplines. http://www.doh.gov.ph/node/143/pdf, 2008.12.
- 65. Universally Accessible Cheaper and Quality Medicines Act of 2008, Congress Of Philipplines. http://www.doh.gov.ph/ra/cheaper_drugs, 2008.12.
- 66. General Regulations for the Enforcement of the Food, Drug & Cosmetic, Department Of Health Office Of The Secretary. http://www.bfad.gov.ph/AO/ao%2061%20s%201968.pdf, 2008.12.
- 67. Guidelines on the Pilot Implementation of the Electronic Essential Drug Price Monitoring(e-EDPMS), Office Of The Senate, http://www.doh.gov.ph/files/ao2008-0014_0.pdf, 2008.12.
- 68. Guidelines Institutionalizing and Strengthening the Essential Drug Price Monitoring System(EDPMS), Office Of The Senate. http://www.bfad.gov.ph/AO/ao2006-0009_doh.pdf, 2006.
- 69. Reporting Adverse Drug Reactions In South Africa, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=17&Desc=Guidelines%20-%20Human%20Medicines, 2008.12.
- 70. Draft Policy on African Traditional Medicine for South Africa, National Ethics Committee for African Traditional Medicine. Medicines Control Council. http://www.doh.gov.za/, 2008.12.
- 71. General Regulations Made In Terms Of The Medicines And Related Substances Act, 1965 (Act No. 101 Of 1965), As Amended, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=27&Desc=Acts%20and%20Regulations, 2008.12.
- 72. Medicines and Related Substances Act, 1965, Government Gazette, http://www.mccza.com/showdocument.asp?Cat=27&Desc=Acts%20and%20Regulations, 2008.
- 73. Medicines and Related Substances Control Amendment Bill, 1997. http://www.hst.org.za/pphc/Phila/medbill.htm, 2008.12.
- 74. Pharmacy Amendment Act, No.6 of 1995. Office Of The President, http://www.doh.gov.za/docs/pharmis-f.html, 2008.12.
- 75. Pharmacy Amendment Act, No.88 of 1997. Office Of The President, http://www.doh.gov.za/docs/pharmis-f.html, 2008.12.
- 76. Pharmacy Amendment Act, No. 1 of 2000, Office Of The President, http://www.doh.gov.za/docs/pharmis-f.html, 2008.12.
- 77. Fees Payable To The Registrar, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=2, 2008.12.
- 78. Andy Gray. Drug Pricing, http://www.hst.org.za/uploads/files/drugs.p, 2008.12.
- 79. Guide To Good Manufacturing Practice For Medicines In South Africa, Medicines Control Council, http://www.mccza.com/showdocument.asp?Cat=1, 2008.12.
- 80. Guideline For The Direct Transmission Of Fees Payable To The Registrar Of Medicines, Medicines Control Council, http://www.mccza.com/showdocument.asp?Cat=2, 2008.12.
- 81. Guidelines On Inspections Involving The GMP Inspectors, Medicines Control Council, http://www.mccza.com/showdocument.asp?Cat=1, 2008.12.
- 82. The impact of rationalised pharmaceutical procurement and distribution and of the essential drugs programme implementation, MEDUNSA School of Pharmacy. http://www.hst.org.za/uploads/files/drgmx_n. 2008.12.
- 83. Implementation Of The Post-Registration Amendments Guideline, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=17&Desc=Guidelines%20-%20Human%20Medicines, 2008.12.
- 84. Package Inserts For Human Medicines, Medicines Control Council. http://www.mccza.com/showdocument.asp?Cat=17&Desc=Guidelines%20-%20Human%20Medicines, 2008.
- 85. 南非藥品信息體系, http://www.doh.gov.za/department/clus_pharma.html, 2008.12.
- 86. Bhutan Medicines Rules & Regulations 2005. Kingdom of Bhutan. http://www.health.gov.bt/downloads/EnglishRegulations.pdf. 2005.
- 87. Guidelines for application for Registration of Medicinal Products 2006(DRA). Drug regulatory authority, http://www.health.gov.bt/downloads/draRegisGuidenew.pdf, 2008.12.
- 88. The Medicines Act Of The Kingdom Of Bhutan 2003. http://www.health.gov.bt/downloads/EnglishMedicinesAct.pdf, 2008.12.
- 89. Procurement Manual rules and procedures 2007 . Royal Government of Bhutan Ministry of Finance, http://www.health.gov.bt/downloads/procurementmanual.pdf, 2008.12.
- 90. Bell JF. Guideline On Continuing Medical Education, ministry of health http://www.health.gov.bt/downloads/CMEguideline07.pdf.
- 91. Drugs, vaccines and equipment division, procurement procedures. ministry of health, http://www.health.gov.bt/dms/dved/procurementProc.pdf, 2008.12.
- 92. Drug Act. 2035 (1978). http://www.dda.gov.np/drugact.php, 2008.12.
- 93. Guidelines on Ethical Promotion of Medicine, 2007. http://www.dda.gov.np/guidance.php, 2008.12.
- 94. Guidelines on Labelling. Department of Drug Administration. http://www.dda.gov.np/guidance.php, 2008.12.
- 95. National Good Pharmacy Practice Guidelines. Nepal Pharmacy Council. http://www.dda.gov.np/guidlines/national_gp, 2008.12.
- 96. Bijulibazar, Kathmandu. Report On Consumption And Quantification Of Modern Drugs For Human Use In Nepal. Department of Drug Administration. http://www.dda.gov.np/quantification/quanti_2001.pdf, 2008.12.
- 97. Bijulibazar, Kathmandu. Report On Quantification Of Drug Consumption In Nepal. Department of Drug Administration. http://www.dda.gov.np/quantification/quanti_2006.pdf, 2008.12.
- 98. Guidelines for Drug Donations. Government of Nepal. http://www.dda.gov.np/guidlines/other_guidence.pdf, 2008.12.
- 99. Rational Drug Use. The Directorate General Of Pharmaceutical Affairs And Drug Control. http://www.moh.gov.om/pharma/rdupeng.pdf, 2008.12.
- 100. Quality Use Of Medicines-– A Decade Of Research,Development And Service Activity. Pharmaceutical Health and Rational use of Medicines Committee. http://www.health.gov.au/internet/main/publishing.nsf/Content/AEC9F819EA0345F7CA256F1800468F04/.
- 101. Australian guidelines for drug donations to developing countries. Australian Pharmaceutical Advisory Council. http://www.health.gov.au/internet/main/publishing.nsf/Content/035470C60EE4E52FCA256F1800468850/.
- 102. The Quality Use of Medicines and Children. Pharmaceutical Health And Rational use of Medicines (PHARM) Committee. http://www.health.gov.au/internet/main/publishing.nsf/Content/55E55D36126F25F7CA2573FC00062A82/.
- 103. The Therapeutic Goods Administration’s risk management approach to the regulation of therapeutic goods. Department Of Health And Ageing Therapeutic Goods Administration. http://www.tga.gov.au/about/tgariskmnt.pdf, 2008.12.
- 104. Policies, Procedures And Methods Used In The Pricing Of Pharmaceutical Products. Pharmaceutical Benefits Pricing Authority. Http://Www.Health.Gov.Au/, 2008.12.
- 105. The National Strategy for Quality Use of Medicines. Pharmaceutical Health And Rational use of Medicines (PHARM) Committee. http://www.health.gov.au/internet/main/publishing.nsf/Content/AEC9F819EA0345F7CA256F1800468F04/.
- 106. The Expectations, the Reality And The Burden Of Drug Donations. Ministy of Healthcare & Nutrition. http://www.health.gov.lk/msd/Page1-9MSD.pdf, 2008.12.
- 107. Dr Nihal Jayathilaka. Improving access to affordable essential drugs. Ministry of health.http://www.wpro.who.int/NR/rdonlyres/1A29C051-DE36-4521-AB7B-812E8274456D/0/03SriLanka2A1.pdf. 2008.12.
- 108. Sri Lanka National Health System Profile. http://www.health.gov.lk/, 2008.12.
- 109. F. K. HLORTSI-AKAKPO, Traditional Medicine. Traditional Medicine Practice Council, http://www.moh-ghana.org/moh/aboutus/policies.asp, 2008.
- 110. Drugs (Licensing, Registering And Advertising) Rules, 1976. the Federal Government, http://www.dcomoh.gov.pk/regulations/drugrules5.php, 2008.12.
- 111. The Drugs Act. http://www.dcomoh.gov.pk/regulations/pharmacyact1967.php, 2008.12.
- 112. Guidelines For cGMP Inspection of Biological Drugs. Ministry of Health. http://www.dcomoh.gov.pk/, 2008.12.
- 113. Guildline For Registration of Biological Drugs. Ministry of Health. http://www.dcomoh.gov.pk/, 2008.12.
- 114. Pakistan- An Introduction. http://www.dcomoh.gov.pk/, 2008.12.
- 115. The Drugs (Labelling and Packing) Rules, http://www.dcomoh.gov.pk/, 2008.12.
- 116. Problem of Irrational Drug Use. Pakistan drug update. http://www.dcomoh.gov.pk/, 2008.12.
- 117. Mohammad Saidul Islam. How Complementary and Alternative Medicine (CAM) is promoted in Bangladesh. The Internet Journal of Alternative Medicine, 2008, 5(2): 1450-1458.
- 118. The Drugs (Control) Ordinance, http://www.mohfw.gov.bd/, 1982.
- 119. Drug Registration Procedure And Requirements In Bangladesh. http://www.mohfw.gov.bd/drug%20registration.htm, 2008.12.
- 120. Drug Act, Government of Bangladesh. 2008.12.
- 121. Code Of Pharmaceutical Marketing Practices. Drugs Administration Ministry of Health And Family Welfare, http://www.mohfw.gov.bd/, 2008.12.
- 122. Regulations, Policies and Standards in Pharmaceutical Industry. Directorate of Drugs Administration, http://www.mohfw.gov.bd/, 2008.12.
- 123. The Bengal Drugs Rules, Government of East Bengal Health and LocalSelf-GovernmentDepartment. 2008.12.
- 124. Bruce Carleton. Post-Marketing Pharmacosurveillance In Canada. http://www.hc-sc.gc.ca/dhp-mps/index-eng.php, 2008.12.
- 125. Wendy Kennedy. The Health Transition Fund (Pharmaceutical Issues). http://www.hc-sc.gc.ca, 2008.12.
- 126. A Comparison of Pharmaceutical Reaseach and Development Spending. Patented Medicine Prices Review Board, http://www.mohfw.gov.bd/, 2008.12.
- 127. Access to Therapeutic Products in Canada, ministry of health. http://www.mohfw.gov.bd/, 2008.12.
- 128. National Pharmaceuticals Strategy (NPS). ministry of health. http://www.mohfw.gov.bd/, 2008.12.
- 129. Gary Fox, Medicines that Work for Canadians (Business Plan for a Drug Effectiveness and Safety Network). http://www.mohfw.gov.bd/, 2008.12.
- 130. Traditional and Complementary Medicine. http://www.myhealth.gov.my/myhealth/eng/ubat_anda_content.jsp?lang=ubat&storymaster=1225785083091&storyid=1225785618675&sub, 2008.12.
- 131. Medicines (Advertisement And Sale)Act, http://www.pharmacy.gov.my/, 2008.12.
- 132. Registration of Pharmacists Act, http://www.pharmacy.gov.my, 2008.
- 133. 馬來西亞藥品管理體系, http://www.pharmacy.gov.my. 2008.12.
- 134. Drug Registration Guidance Document, National Pharmaceutical Control Bureau, http://www.pharmacy.gov.my, 2008.
- 135. drug policy, http://www.nppaindia.nic.in/drug_pol86/txt1.html, 2008.
- 136. Drugs(Prices Control) Order. Ministry of Chemicals and Fertilizers. http://www.nppaindia.nic.in/drug_price95/txt1.html, 2008.12.
- 137. Modifications in Drug Policy. http://www.nppaindianic.in/drug_pol86/modif86/mod1.html, 2008.12.
- 138. Pharmaceutical Policy-2002. Prime Minister’s Advisory Council. http://www.nppaindia.nic.in/may-2002/policy-02.html, 2008.12.
- 139. Dte.GHS, Central Drugs Standard Control Organization-Laws Pertaining To Manufacture And Sale Of Drugs In India, Ministry of Health and Family Welfare. http://www.cdsco.nic.in/html/law.htm.
- 140. The Drugs And Cosmetics Act And Rules. Ministry of Health And Family Welfare. http://www.cdsco.nic.in/html/Copy%20of%201.%20D&CAct121.pdf, 2008.12.
- 141. Price Control Order (DPCO), National Pharmaceutical Pricing Authority . http://www.pharmaceutical-drug-manufacturers.com/pharmaceutical-policies/drugs-price-control-order.html, 2008.12.
- 142. Procedure for Price Fixation. National Pharmaceutical Pricing Authority, http://www.nppaindia.nic.in/may-2002/procedure-bd.html, 1 2008.12.
- 143. Procedure for Pricing of Formulations. National Pharmaceutical Pricing Authority. http://www.nppaindia.nic.in/may2002/procedure-form.html, 2008.12.
- 144. Central Drugs Standard Control Organization-Drugs Control Administration. Drugs Control Administration. http://www.cdsco.nic.in/html/Drugs_ContAd.html, 2008.12.
- 145. 中華人民共和國藥品管理法, 國家食品藥品監督管理局. http://www.sda.gov.cn/WS01/CL0064/23396.html, 2008.12.
- 146. 中華人民共和國藥品管理法實施條例, 國家食品藥品監督管理局. http://www.sda.gov.cn/WS01/CL0062/23395.html, 2008.12.
- 147. WHO. Essential medicines: access, quality and rational use – highlights of 2000, www.who.int/mip2001/files/2158/MIP01_APR_HTP2.en.pdf, 2008.12.
- 148. WHO. The WHO Essential Medicines List (EML): 30th anniversary. www.who.int/entity/medicines/events/fs/en/, 2008.12.
- 149. WHO. Comparative analysis of national drug policies. www.wpro.who.int/NR/rdonlyres/F1EFC301-FD5E-4BEE-9FD7-656965FD882B/0/EDMnewsletterECACPWHOyear2.pdf, 2008.12.
- 150. WHO Regional Office of the Western Pacific. Drug Price Control Bills in the Philippines/ Ethical Practices in Medicines Regulation and Procurement. Essential drug & medicine policy, 2008.12.
- 151. WHO. The Role of Education in the Rational Use of Medicines. www.wpro.who.int/NR/rdonlyres/8B64881B-DE1A-4A31-B670-B87265FBBB7F/0/EDMP_Dec04.pdf, 2008.12.
- 152. WHO. Malaysia formulates national medicines policy. Essential drug & medicine policy, 2002, 1(1):537-542.
- 153. WHO. Strengthening ADR Monitoring in the Philippines. Essential drug & medicine policy, 2003, 2(1): 765-769.
- 154. WHO. Computerized Drug Registration- The Lao People’s Democratic Republic/ Monitoring and Assessing the Pharmaceutical Situation in Malaysia. Essential drug & medicine policy, 2002, 1(2): 253-258.
- 155. WHO. Assessment of the Distribution Practices of Medicines in thePhilippines. Essential drug & medicine policy, 2004, 3(2): 753-760.
- 156. WHO. Philippines Chosen as a MeTA Pilot Country/ Cheaper Medicines Bill in the Philippines/ Philippines Develops Quality Seal System for Pharmaceuticals. Essential drug & medicine policy, 2007, 7(3): 341-346.
- 157. WHO. Medicines Price Monitoring in Malaysia. Essential drug & medicine policy, 2006, 5(1): 445-448.
- 158. WHO. Annual Report 2001:Essential Drugs and Medicines Policy: Extending the Evidence Base. www.who.int/mip2002/index.pl%3Fid=2304&isa=Item&field_name=item_attachment_file&op=download_file, 2008.12.
- 159. WHO. How to develop a national formulary based on the WHO model formulary. www.who.int/emlib/docs/National_MF_Manual2004-8.pdf, 2008.12.
- 160. WHO. Medicine Prices in Ghana: A comparative study of Public, Private and Mission sector medicine prices. www.afro.who.int/dsd/survey_reports/ghana.pdf, 2008.12.
- 161. WHO. Biregional Workshop On Promoting Ethical Practices In Medicines Registration And Procurement., whqlibdoc.who.int/wpro/2006/RS_2005_GE_12_MAA.pdf, 2008.12.
- 162. WHO. Essential drugs and other supplies. http://www.searo.who.int/EN/Section313/Section1515_6124.htm, 2008.12.
- 163. WHO. rational use of medicines in the lao people’s democratic republic strategy/ combating counterfeit drugs in the lao people’s democratic republic. Essential drug & medicine policy, 2003, 2(2): 752-756.
- 164. WHO. Drug Supply Management in the Context of IMCI（Drug Supply and Management Training in South Africa. whqlibdoc. who.int/searo/2001/SEA_Drugs_152.pdf, 2008.12.
- 165. WHO. Rational Drug Use (RDU). www.emro.who.int/Publications/EMHJ/1305/article25.htm, 2008.12.
- 166. WHO. Use of the WHO certification scheme on the quality of pharmaceutical products moving in international commerce. whqlibdoc.who.int/hq/1994/WHO_DAP_94.21.pdf, 2008.12.
- 167. WHO. Uganda pharmaceutical sector baseline survey. whqlibdoc.who.int/hq/2002/a87427_eng.pdf, 2008.12.
- 168. WHO. An assessment of the pharmaceutical sector. whqlibdoc.who.int/hq/2002/a87429_eng.pdf, 2008.12.
- 169. WHO. Effective drug regulation. www.who.int/entity/medicines/areas/rational_use/startingstrengdrugbulletin.pdf, 2008.12.
- 170. WHO. Reports World Medicines Situation. whqlibdoc.who.int/hq/1994/WHO_DAP_94.21.pdf, 2008.12.
- 171. WHO. Essential Medicines List. whqlibdoc.who.int/hq/2006/WHO_PSM_PAR_2006.5_eng.pdf, 2008.12.
- 172. WHO. Successful partnership in Pakistan for rational use and management of medicines. Essential Drugs in Brief, 2003, 3(9).
- 173. WHO. Access to affordable essential medicines. www.who.int/entity/medicines/mdg/MDG08ChapterEMedsEn.pdf, 2008.12.
- 174. WHO. Regional Strategy For Improving Access To Essential Medicines In The Western Pacific Region, 2004-2009, 2008.12.
- 175. Implementing Guidelines For The Philippines NDP System. Ministry of health. http://www.doh.gov.ph/ndp_issuances, 2008.12.
- 176. Lao national drug policy programme. Department for democracy and social development.http://www.globala.sida.se/sida/jsp/sida.jsp?d=118&a=2218&language=en_US, 2008.12.
- 177. Oman National Drug Policy. The Directorate General Of Pharmaceutical Affairs And Drug Control. http://www.moh.gov.om/pharma/ndpeng.pdf, 2008.12.
- 178. National medicine policy ( Australia ). Department of health and aging. http://www.health.gov.au/internet/main/publishing.nsf/Content/0241A32640D477CACA256F18004685E4/.
- 179. National drug policy (Bhutan). Department of Medical Services Ministry of Health Royal Government of Bhutan. http://www.health.gov.bt/downloads/drugPolicy.pdf, 2008.12.
- 180. National Drug Policy for South Africa. Minister of Health. http://www.doh.gov.za/docs/policy/drugsjan1996.pdf, 2008.12.
- 181. National Drug Policy (Nepal). Commitment of Government Of Nepal. http://www.google.cn/search?hl=zh-CN&newwindow=1&q=National+Drug+Policy+nepal&btnG= Google+%E6%90%9C%E7%B4%A2&meta= &aq=f&oq=, 2008.12.
- 182. National Medicinal Drug Policy For SriLanka, http://www.who.int/medicines/areas/policy/NMDP_SriLanka.pdf, 2008.12.
- 183. National drug policy (Pakistan). Ministry of health. http://www.dcomoh.gov.pk/publications/ndp.php, 2008.12.
- 184. National drug policy (Uganda). The National Drug Authority, http://www.nda.or.ug/index.php, 2008.12.
- 185. National Medicine Policy (Afghanistan). Ministry of Health. http://ispb.univ-lyon1.fr/Lyon%20Kaboul/politique_de_sante_en_afghanistan/rapports/Politique%20du%20m%E9dicament.pdf, 2008.12.
- 186. National Pharmaceuticals Strategy ( Canada ). Health Canada, http://www.hc-sc.gc.ca/hcs-sss/alt_formats/hpb-dgps/pdf/pubs/2006-nps-snpp/2006-nps-snpp-eng.pdf, 2008.12.
- 187. Ghana National Drug Policy. Ministry of Health (GNDP) Ghana, http://www.who.int/countries/gha/publications/Ghana_National_DrugPolicy_2nd_Edition.pdf, 2008.12.
- 188. National medicines policy of Malaysia. Ministry of health Malaysia. http://www.pharmacy.gov.my/, 2008.12.
- 189. National drug policy (Bangladesh) . Ministry Of Health And Family Welfare . http://www.ailonline.net/skf_new/images/files/.
- 190. National_Drug_Policy_May_05.pdf, 2008.12.
- 191. 張新平,李少麗. 藥物政策學. 北京: 科學出版社, 2003.